Interleukin (IL)-4 is thought to contribute to the Th2 type of immune respo
nse and hence the development of allergic reactions such as asthma. In asth
matic patients, the airway epithelium expresses increased amounts of the ce
ll surface adhesion molecule intercellular adhesion molecule (ICAM)-1 (CD54
). One cytokine capable of inducing ICAM-1 in airway epithelial cells, tumo
r necrosis factor-alpha (TNF-alpha), is present in asthma. This study evalu
ated if IL-4 either alone or together with TNF-alpha costimulation might mo
dulate CD54 expression by human bronchial epithelial cells (HBECs). CD54 po
sitivity increased in response to IL-4 (16 +/- 2% positive vs. 3 +/- 1%, P
< 0.01); greater induction of CD54 resulted from TNF-alpha (45 +/- 2%, P <
0.001). Costimulation with TNF-alpha plus IL-4 further augmented expression
(56 +/- 1%, P < 0.05). Immunoperoxidase results were confirmed by flow cyt
ometry. RT-PCR revealed no increase in ICAM-1 mRNA expression under control
conditions or after stimulation with IL-4 alone. TNF-alpha increased IL-4
mRNA, and IL-4 potentiated this. Functionally, IL-4 augmented the adhesion
of THP-1 monocyte/macrophage cells to monolayers of HBECs both alone and in
the presence of TNF-alpha. We conclude that 1) IL-4 augments epithelial ce
ll ICAM-1 expression, 2) IL-4 potentiates the adhesion of THP-1 monocyte/ma
crophage cells to epithelial cells, and 3) modulation of epithelial cell IC
AM-1 expression by IL-4 may play a role in the immunopathology of bronchial
asthma.